SignaBlok is a biotech company with a novel technology, called SCHOOL, which provides a new way to interrupt cell signaling. The challenge...
Oligomerix and Axxiem have been working together for many years. With their most recent website update, Oligomerix commissioned Axxiem to create an...
Aerpio Pharmaceuticals, a biopharmaceutical company focused on leveraging Tie2 activation for ocular disease and vascular stabilization, requested a website that showcases their...
Over the years, Axxiem has worked with COUR Pharmaceuticals to modernize their website and develop customized medical animations and still graphics that...